drugset / Trial / NCT02740426

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

NCT02740426

Phase 2 Unknown 200 enrolled Peking University First Hospital
RandomizedSingle-groupOpen-labelPrevention

Summary

This clinical trial is designed to evaluate the efficacy of single immediate intravesical chemotherapy instillation in the prevention of bladder recurrence after diagnostic ureteroscopy for upper tract urothelial carcinoma (UTUC) patients.

Timeline

Start
2016-08
Primary completion
2021-05
Completion
2022-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pirarubicin Small molecule 40 mg Intravenous